Filing Flows

Filing Flows › Staar Surgical (STAA) › Q1 2025

Staar Surgical (STAA) Q1 2025 earnings results (first quarter 2025)

10-Q filed May 7, 2025

Staar Surgical (STAA) reported revenue of $42.6M for the first quarter 2025 (Q1 2025), -45% from a year earlier and -13% from the quarter before. Operating margin was -134.8%, net loss $54.2M (127.3% of revenue).

Revenue$42.6M
Year over year-45%
Quarter over quarter-13%
Operating margin-134.8%
Net earnings−$54.2M

Staar Surgical, Q1 2025: revenue $42.6M (-45% year over year), operating margin -134.8%, net loss $54.2M, operating cash flow −$5.7M. The chart follows the revenue to costs, profit and cash.

Q1 2025AmountQ/QY/Y
Revenue$42.6M-13%-45%
Operating profit−$57.4M——
Net earnings−$54.2M——
Operating cash flow−$5.7M——

What changed

Revenue was $42.6M in Q1 2025, down 45% year over year and down 13% from the previous quarter.

Gross margin was 65.8%, down 13.1 points from a year earlier. Operating costs exceeded revenue by $57.4M, an operating margin of -134.8%. Operating expenses grew 35% against a revenue fall of 45%. The quarter ended with a net loss of $54.2M, wider than the previous quarter's $34.2M loss.

Operating cash flow was −$5.7M. Non-cash charges added back $2.3M of depreciation and $6.0M of share-based compensation. Working capital and other items added $40.1M. Capital expenditures of $1.5M exceeded it, leaving free cash flow of −$7.2M.

Questions

What was Staar Surgical's revenue in the first quarter 2025?

Staar Surgical (STAA) reported revenue of $42.6M for the first quarter 2025 (Q1 2025), -45% from a year earlier and -13% from the quarter before.

Was Staar Surgical profitable in the first quarter 2025?

Operating loss was $57.4M (-134.8% of revenue) and net loss $54.2M.

Open the interactive Sankey →

Source: Staar Surgical 10-Q on SEC EDGAR.